Ajovy is a prescription drug that is used to prevent migraine headaches. It was approved by the U.S. Food and Drug Administration (FDA) in 2018 and is now widely used by people suffering from chronic migraine. While Ajovy has proven to be an effective treatment for some patients, it is important to understand the potential side effects associated with the drug in order to ensure its safe and effective use. This article will explore the potential side effects of Ajovy and how they can be managed.
Ajovy is a medication that is used to prevent migraine headaches. It is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) receptors on the surface of nerve cells in the brain. By blocking the action of CGRP, Ajovy is able to reduce the frequency and intensity of migraine headaches. Ajovy is administered as an injection once every four weeks and is available in both an auto-injector and a prefilled syringe.
Like all medications, Ajovy can cause side effects. The most common side effects of Ajovy are injection site reactions, such as redness, itching, pain, swelling, and irritation. Other common side effects include nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects. These include anaphylaxis, a severe allergic reaction that can cause difficulty breathing, hives, and swelling of the face, lips, tongue, and throat. It is important to seek medical attention immediately if any of these symptoms occur. Ajovy can also cause liver damage, which can lead to jaundice, dark urine, and abdominal pain. It is important to speak to a doctor if any of these symptoms occur. Additionally, Ajovy can cause an increase in blood pressure, which can lead to dizziness, headaches, and blurred vision.
The side effects of Ajovy can be managed with proper monitoring and treatment. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to monitor for any changes in blood pressure, as this can be an indication of an increase in blood pressure. It is also important to stay hydrated and get plenty of rest. Additionally, it is important to avoid alcohol and other substances that can increase the risk of side effects.
Ajovy is an effective medication for preventing migraine headaches, but it is important to understand the potential side effects associated with the drug. Common side effects include injection site reactions, nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects, such as anaphylaxis, liver damage, and increased blood pressure. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to stay hydrated and get plenty of rest, as well as avoid alcohol and other substances that can increase the risk of side effects.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation